Colossal Biosciences Series A

Health Care · United States · $60M

Colossal Biosciences raised a $60 million Series A round in March 2022, led by Thomas Tull and At One Ventures, with participation from Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Paris Hilton, BOLD Capital, First Light Capital Group, Boost VC, Jazz Venture Partners, Builders VC, Green Sands Equity, Draper Associates, and Charles Hoskinson, among others, bringing the company total funding to $75 million.